申请人:Teijin Pharma Limited
公开号:EP3305785A1
公开(公告)日:2018-04-11
The purpose of the present invention is to provide a compound having an excellent CDK4/6 inhibiting activity. The present invention is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof.
本发明的目的是提供一种具有优异 CDK4/6 抑制活性的化合物。本发明是通式(I)代表的化合物或其药学上可接受的盐。